SHAK, STEVEN,PATON, VIRGINIA, E.,DESMOND-HELLMANN, SUSAN DIANE
申请号：
DK98963840
公开号：
DK1037926T3
申请日:
1998.12.10
申请国别(地区):
DK
年份:
2014
代理人:
摘要：
The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin.
